Friday, July 10, 2026

pharma · Post-bariatric hypoglycaemia · Cushing's disease

Recordati Ireland

Recordati Ireland clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Cork, IE HQ
2002 Founded
40 Employees
EMA registrant Type
Company details
Status
Public
HQ
Cork, IE
Founded
2002
Employees
40
Programs
4
Drugs
11
Patents
0
Intelligence · Clinical Programs

Recordati Ireland projects

2 ClinicalTrials.gov programs sponsored by Recordati Ireland.

Recordati Ireland has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. SOM230-RECAG-PK-0605

    Recordati Ireland

    Post-bariatric hypoglycaemia

    phase 1 other active

    1 trial
  2. SOM230-RECAG-PK-612

    Recordati Ireland

    Post-bariatric hypoglycaemia

    phase 1 other active

    1 trial

Frequently asked questions

How many clinical projects does Recordati Ireland have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.